We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Characteristics and therapeutic strategies of brain and cranial radiation-induced sarcoma: analysis of 165 cases from our case experience and comprehensive review.
- Authors
Onishi, Shumpei; Yamasaki, Fumiyuki; Kinoshita, Yasuyuki; Amatya, Vishwa J; Takayasu, Takeshi; Yonezawa, Ushio; Taguchi, Akira; Go, Yukari; Takeshima, Yukio; Horie, Nobutaka
- Abstract
Background Radiation-induced sarcoma (RIS) is among the neoplasms potentially caused by radiation therapy (RT) for brain tumors. However, the clinical characteristics of and ideal treatment for RIS are unclear. We analysed our case experience and conducted a comprehensive literature review to reveal the characteristics of brain and cranial RIS. Methods We analysed 165 cases of RIS from the literature together with the RIS case treated at our institution. In each case, the latency period from irradiation to the development of each RIS and the median overall survival (OS) of the patients was analysed by Kaplan–Meier analysis. Spearman's correlation test was used to determine the relationship between the latency period and radiation dose or age at irradiation. Results The mean age at the development of RIS was 39.63 ± 17.84 years. The mean latency period was 11.79 ± 8.09 years. No factors associated with early development of RIS were detected. The median OS was 11 months, with fibrosarcoma showing significantly shorter OS compared with osteosarcoma and other sarcomas (p = 0.0021), and intracranial RIS showing a worse prognosis than extracranial RIS (p < 0.0001). Patients treated with surgery (p < 0.0001) and postoperative chemotherapy (p = 0.0157) for RIS presented significantly longer OS, whereas RT for RIS was not associated with a survival benefit. Conclusions Although prognosis for RIS is universally poor, pathological characteristics and locations are associated with worse prognosis. Surgery and chemotherapy may be the ideal treatment strategies for RIS.
- Publication
Japanese Journal of Clinical Oncology, 2023, Vol 53, Issue 10, p905
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyad078